Active Ingredient History

NOW
  • Now
Ferric derisomaltose, sold under the brand name Monoferric, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD). It was approved for use in the United States in January 2020. It is given intravenously.   Wikipedia

Drug Pricing (per unit)

Australia

$107.7047 - $215.4016
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

iron isomaltoside | isomaltoside

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue